Avery K Huber - JoVE Visualize

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Biorxiv : the Preprint Server for Biology|February 23, 2026

Enhancing ML-based binder design with high-throughput screening: a comparison of mRNA and yeast display technologiesZhiyuan Yao, McGuire Metts, Avery K Huber, et al.

Protein Science : a Publication of the Protein Society|July 10, 2026

Enhancing machine learning-based binder design with high-throughput screening: A comparison of mRNA and yeast display technologiesZhiyuan Yao, McGuire Metts, Avery K Huber, et al.

Molecular Therapy. Methods & Clinical Development|December 17, 2024

Intrathecal or intravenous AAV9-IDUA/RGX-111 at minimal effective dose prevents cardiac, skeletal and neurologic manifestations of murine MPS ILalitha R Belur, Avery K Huber, Hillary Mantone, et al.

Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Biorxiv : the Preprint Server for Biology|February 23, 2026

Enhancing ML-based binder design with high-throughput screening: a comparison of mRNA and yeast display technologiesZhiyuan Yao, McGuire Metts, Avery K Huber, et al.

Protein Science : a Publication of the Protein Society|July 10, 2026

Enhancing machine learning-based binder design with high-throughput screening: A comparison of mRNA and yeast display technologiesZhiyuan Yao, McGuire Metts, Avery K Huber, et al.

Molecular Therapy. Methods & Clinical Development|December 17, 2024

Intrathecal or intravenous AAV9-IDUA/RGX-111 at minimal effective dose prevents cardiac, skeletal and neurologic manifestations of murine MPS ILalitha R Belur, Avery K Huber, Hillary Mantone, et al.

Pageof 1